Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Remdesivir Market Forecast: What Value Will The Market Reach By 2030?
The remdesivir market size has experienced significant expansion over recent years. It is anticipated to increase from $8.52 billion in 2025 to $11.17 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 31.2%. The historical growth of this market can be attributed to the emergency use authorization of remdesivir, elevated hospitalization rates during COVID-19 peaks, limited choices for antiviral treatments, increasing public awareness of antiviral therapies, and the rapid establishment of hospital procurement channels.
The remdesivir market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $17.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. This expansion during the forecast period is attributable to factors such as the creation of new remdesivir formulations, wider acceptance of oral and pre-filled injectable solutions, the proliferation of telemedicine for antiviral delivery, an increase in government efforts for COVID-19 treatment, and the rise of online pharmacies and home delivery options. Key trends anticipated for the forecast period encompass an escalating demand for intravenous antiviral treatments, greater uptake of oral antiviral types, an increase in hospitalizations and intensive care needs for COVID-19, the broadening of online and physical pharmacy distribution networks, and the introduction of ready-to-administer injectable and powdered solutions.
Get A Free Sample Report With In-Depth Market Insights:
Remdesivir Market Expansion Drivers: What’s Shaping Future Growth?
The increasing government expenditure is expected to propel the growth of the remdesivir market going forward. Government expenditure, also known as government spending, refers to the total amount of money that a government or public sector entity allocates and disburses to finance its operations, programs, services, and projects. Government expenditure is instrumental in the growth and accessibility of Remdesivir, especially during public health crises. By providing funding, regulatory support, purchasing power, and research investments, governments can contribute to the availability and affordability of this critical antiviral medication. For instance, in April 2025, according to the American Medical Association, a US-based Professional organizations, in 2023, U.S. health spending climbed 7.5% to $4.9 trillion, or $14,570 per capita, outpacing the 4.6% increase seen in 2022. Therefore, the increasing government spending is driving the growth of the remdesivir market.
Remdesivir Market Segment Breakdown: Which Categories Lead On Revenue?
The remdesivir market covered in this report is segmented –
1) By Route Of Administration: Oral, Intravenous
2) By Dosage Form: Tablets, Frozen Solution, Lyophilized Solution
3) By Distribution Channel: Hospitals, Clinics, Drug Stores/Pharmacies, Online, Other Distribution Channels
Subsegments:
1) By Oral: Tablet Formulation, Liquid Formulation
2) By Intravenous: Ready-To-Use Injectable, Lyophilized Powder For Injection
Remdesivir Market Leading Players And Competitive Positioning
Major companies operating in the remdesivir market are Gilead Sciences Inc., BrightGene Bio-Medical Technology Co Ltd, Hainan Haiyao Co. Ltd., Sichuan Kelun Pharmaceutical Co. Ltd., Hunan Warrant Pharmaceutical, Cipla Limited, Dr Reddy’s Laboratories Ltd., Shenzhen BORUI Pharmaceutical Technology Co. Ltd., Hetero Labs Limited, Mylan N.V., Zydus Cadila Health Care Limited, Syngene International Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Teva Pharmaceutical Industries, Ferozsons Laboratories Limited, Jubilant Life Sciences, Laurus Labs, Macleods Pharmaceuticals, Natco Pharma, Sandoz Group AG, Strides Pharma Science Limited, Torrent Pharmaceuticals, Beximco Pharmaceuticals Ltd., Fresenius Kabi, Gland Pharma Limited, Hikma Pharmaceuticals, Lark Laboratories
View The Full Remdesivir Market Report:
Remdesivir Market Largest Region By Revenue And Market Share
North America was the largest region in the remdesivir market in 2025. Middle East is expected to be the fastest growing region in the remdesivir market report during the forecast period. The regions covered in the remdesivir market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model